CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia.
Montraveta A, Lee-Vergés E, Roldán J, Jiménez L, Cabezas S, Clot G, Pinyol M, Xargay-Torrent S, Rosich L, Arimany-Nardí C, Aymerich M, Villamor N, López-Guillermo A, Pérez-Galán P, Roué G, Pastor-Anglada M, Campo E, López-Guerra M, Colomer D.
Montraveta A, et al. Among authors: campo e.
Oncotarget. 2016 Feb 2;7(5):5507-20. doi: 10.18632/oncotarget.6685.
Oncotarget. 2016.
PMID: 26701728
Free PMC article.